Company news

Nippon Chemiphar Co., Ltd. news in 2026

Nippon Chemiphar Co., Ltd.'s news releases, calls and decks from 2026, newest first.

View company

Patient Enrollment Started for Phase IIa Clinical Trial on δ-Opioid Receptor Agonist NC-2800 in Patients with Depression.

January 15, 2026